Overview

Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study investigates the efficacy of landiolol versus placebo in patients with out-of-hospital cardiac arrest (OHCA) and refractory ventricular fibrillation (electrical storm).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Landiolol